Clinicopathological utility of sialoglycoconjugates in diagnosing and treating colorectal cancer.
暂无分享,去创建一个
Jianjun Gao | P. Song | Wei Tang | N. Kokudo | Y. Inagaki | M. Nakata
[1] Y. Ueda,et al. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. , 2013, World journal of gastroenterology.
[2] S. Yamashita,et al. Clinicopathological subclassification of biliary cystic tumors: Report of 4 cases with a review of the literature. , 2013, Intractable & rare diseases research.
[3] Y. Collan,et al. Loss of MUC2 expression predicts disease recurrence and poor outcome in colorectal carcinoma , 2013, Tumor Biology.
[4] Wei Tang,et al. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. , 2013, Bioscience trends.
[5] H. Nakada,et al. Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells. , 2012, Bioscience trends.
[6] Yuemao Shen,et al. Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugs. , 2012, Drug discoveries & therapeutics.
[7] Jianjun Gao,et al. Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence. , 2012, Bioscience trends.
[8] P. Song,et al. "Knowledge into action" Exploration of an appropriate approach for constructing evidence-based clinical practice guidelines for hepatocellular carcinoma. , 2012, Bioscience trends.
[9] Minyoung Lee,et al. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells. , 2012, Biochemical pharmacology.
[10] Minyoung Lee,et al. Cleavage of ST6Gal I by Radiation-Induced BACE1 Inhibits Golgi-Anchored ST6Gal I-Mediated Sialylation of Integrin β1 and Migration in Colon Cancer Cells , 2012, Radiation oncology.
[11] K. Yamashita,et al. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. , 2012, Glycobiology.
[12] G. Francini,et al. CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab , 2012, Cancer investigation.
[13] E. Cuevas,et al. sLea and sLex expression in colorectal cancer: implications for tumourigenesis and disease prognosis. , 2011, Histology and histopathology.
[14] S. Bellis,et al. Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma Cells* , 2011, The Journal of Biological Chemistry.
[15] Jianjun Gao,et al. Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth. , 2011, Bioscience trends.
[16] Hoguen Kim,et al. Loss of E-cadherin and MUC2 Expressions Correlated with Poor Survival in Patients with Stages II and III Colorectal Carcinoma , 2011, Annals of Surgical Oncology.
[17] Y. Inagaki,et al. c-Met: A potential therapeutic target for hepatocellular carcinoma. , 2011, Drug discoveries & therapeutics.
[18] Upender Manne,et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas , 2010, Cancer.
[19] M. Ducreux,et al. Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases , 2010, Annals of Surgical Oncology.
[20] S. Nishimura,et al. An essential epitope of anti-MUC1 monoclonal antibody KL-6 revealed by focused glycopeptide library. , 2009, Journal of the American Chemical Society.
[21] A. Takayanagi,et al. Isolation and characterization of anti-T-antigen single chain antibodies from a phage library. , 2009, Bioscience trends.
[22] M. Makuuchi,et al. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma. , 2009, Hepato-Gastroenterology.
[23] Y. Zhuo,et al. Tumor cell migration and invasion are regulated by expression of variant integrin glycoforms. , 2008, Experimental cell research.
[24] D. Santini,et al. Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. , 2007, Glycobiology.
[25] M. Makuuchi,et al. Subcellular localization of KL-6 mucin in colorectal carcinoma cell lines: association with metastatic potential and cell morphology. , 2007, Oncology reports.
[26] M. Grimm,et al. Comparative Analysis of Predictive Biomarkers for Therapeutical Strategies in Colorectal Cancer , 2007, Annals of Surgical Oncology.
[27] M. Makuuchi,et al. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. , 2006, World journal of gastroenterology.
[28] C. Vázquez‐Martín,et al. Elevation of ST6Gal I Activity in Malignant and Transitional Tissue in Human Colorectal Cancer , 2005, Oncology.
[29] J. Wakefield,et al. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. , 2005, Cancer research.
[30] J. Kihlberg,et al. Role of the Human ST6GalNAc-I and ST6GalNAc-II in the Synthesis of the Cancer-Associated Sialyl-Tn Antigen , 2004, Cancer Research.
[31] C. Vázquez‐Martín,et al. Correlation Analysis between Tumorous Associated Antigen Sialyl-Tn Expression and ST6GalNAc I Activity in Human Colon Adenocarcinoma , 2004, Oncology.
[32] K. Kumamoto,et al. Loss of Disialyl Lewisa, the Ligand for Lymphocyte Inhibitory Receptor Sialic Acid-Binding Immunoglobulin-Like Lectin-7 (Siglec-7) Associated with Increased Sialyl Lewisa Expression on Human Colon Cancers , 2004, Cancer Research.
[33] T. Ando,et al. Synthesis of Disialyl Lewis a (Lea) Structure in Colon Cancer Cell Lines by a Sialyltransferase, ST6GalNAc VI, Responsible for the Synthesis of α-Series Gangliosides* , 2003, Journal of Biological Chemistry.
[34] K. Arisawa,et al. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. , 2003, Hepato-gastroenterology.
[35] T. Irimura,et al. The epitope recognized by the unique anti-MUC1 monoclonal antibody MY.1E12 involves sialyl alpha 2-3galactosyl beta 1-3N-acetylgalactosaminide linked to a distinct threonine residue in the MUC1 tandem repeat. , 2002, Journal of immunological methods.
[36] R. Kannagi. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. , 2002, Current opinion in structural biology.
[37] P. Kirkham,et al. Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: Expression in normal GI tract and colon tumors , 2002, International journal of cancer.
[38] A. Hölscher,et al. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl‐Lewisa and sialyl‐Lewisx antigens in colorectal adenocarcinoma , 2002, Histopathology.
[39] Kan Yang,et al. Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2 , 2002, Science.
[40] I. van Seuningen,et al. Transcriptional regulation of the 11p15 mucin genes. Towards new biological tools in human therapy, in inflammatory diseases and cancer? , 2001, Frontiers in bioscience : a journal and virtual library.
[41] R. Goodlad,et al. Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. , 2001, Glycobiology.
[42] A. Nanashima,et al. Circulating sialyl Lewisx, sialyl Lewisa, and sialyl Tn antigens in colorectal cancer patients: multivariate analysis of predictive factors for serum antigen levels , 2001, Journal of Gastroenterology.
[43] W. Hohenberger,et al. CEA and CA 19-9 measurement as a monitoring parameter in metastatic colorectal cancer (CRC) under palliative first-line chemotherapy with weekly 24-hour infusion of high-dose 5-fluorouracil (5-FU) and folinic acid (FA). , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[44] O. Topolcan,et al. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence. , 2000, Anticancer research.
[45] D. Santini,et al. β‐galactoside α2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with sambucus nigra agglutinin , 2000, International journal of cancer.
[46] H. Weiss,et al. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[47] T. Hamamoto,et al. Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase. , 2000, Biochemical and biophysical research communications.
[48] M. Páez de la Cadena,et al. Immunohistochemical Analysis of Sialic Acid and Fucose Composition in Human Colorectal Adenocarcinoma , 2000, Tumor Biology.
[49] N. Kohno,et al. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis. , 1999, The journal of medical investigation : JMI.
[50] S. Nordling,et al. Sialyl Tn Is a Frequently Expressed Antigen in Colorectal Cancer: No Correlation with Patient Prognosis , 1999, Oncology.
[51] M. Tanaka,et al. CEA and CA 19-9 as prognostic indexes in colorectal cancer. , 1999, Hepato-gastroenterology.
[52] G. Niehans,et al. Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps , 1999, International journal of cancer.
[53] N. Kohno,et al. Immunoreactive MUC1 Expression at the Deepest Invasive Portion Correlates with Prognosis of Colorectal Cancer , 1998, Oncology.
[54] S. Baldus,et al. Coexpression of MUC1 mucin peptide core and the thomsen‐friedenreich antigen in colorectal neoplasms , 1998, Cancer.
[55] H. Stein,et al. MUC2 gene suppression in human colorectal carcinomas and their metastases: in vitro evidence of the modulatory role of DNA methylation. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[56] A. Cailleux,et al. Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. , 1997, European journal of cancer.
[57] M. Kitajima,et al. Prognostic values of serum CA19-9 and CEA levels for colorectal cancer. , 1997, Oncology Report.
[58] R. Kannagi,et al. Altered mRNA expression of specific molecular species of fucosyl‐ and sialyl‐transferases in human colorectal cancer tissues , 1997, International journal of cancer.
[59] C. Stanners,et al. Cell-surface levels of human carcinoembryonic antigen are inversely correlated with colonocyte differentiation in colon carcinogenesis. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[60] M. Páez de la Cadena,et al. Sialic acid levels in serum and tissue from colorectal cancer patients. , 1997, Cancer letters.
[61] S. Hakomori. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.
[62] M. Hanski,et al. Fucosyltransferase III and sialyl-Lex expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue , 1996, Glycoconjugate Journal.
[63] Y. Kim,et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. , 1996, Gastroenterology.
[64] T. Irimura,et al. A Novel Monoclonal Antibody Specific for Sialylated MUC1 Mucin , 1996, Japanese journal of cancer research : Gann.
[65] K. Krause,et al. Quantitative lectinhistochemical and immunohistochemical studies on the occurrence of alpha(2,3)‐ and alpha(2,6)‐linked sialic acid residues in colorectal carcinomas. Relation to clinicopathologic features , 1995, Cancer.
[66] S. Oikawa,et al. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen , 1994, Clinical & Experimental Metastasis.
[67] S. Kamihira,et al. An immunohistochemical employer monoclonal antibodies against Lea, sialyl Lea, Lex, and sialyl Lex antigens in primary colorectal, carcinomas and lymph node and hepatic lesions , 1994, Journal of Gastroenterology.
[68] S. Kamihira,et al. Immunohistochemical expression of sialyl lex antigen in relation to survival of patients with colorectal carcinoma , 1993, Cancer.
[69] T. Irimura,et al. Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. , 1993, Cancer research.
[70] T. Irimura,et al. Regulation of sialomucin production in colon carcinoma cells. , 1993, The Journal of biological chemistry.
[71] R. Kannagi,et al. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. , 1993, Cancer research.
[72] D. Milne,et al. Membranous expression of carcinoembryonic antigen (CEA) in the normal cervical squamous mucosa , 1992, The Journal of pathology.
[73] Judith P. Johnson. Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease , 1991, Cancer and Metastasis Reviews.
[74] S. Hakomori,et al. Sialosyl‐Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients , 1990, Cancer.
[75] N. Peat,et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. , 1990, The Journal of biological chemistry.
[76] J. Taylor‐Papadimitriou,et al. A short sequence, within the amino acid tandem repeat of a cancer‐associated mucin, contains immunodominant epitopes , 1989, International journal of cancer.
[77] N. Kohno,et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. , 1988, Japanese journal of clinical oncology.
[78] I. Goldstein,et al. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. , 1987, The Journal of biological chemistry.
[79] N. Zamcheck,et al. Effect of heterogeneity of carcinoembryonic antigen on liver cell membrane binding and its kinetics of removal from circulation. , 1985, Cancer research.
[80] W. Bodmer,et al. Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in culture , 1981, International journal of cancer.
[81] P. Gold,et al. SPECIFIC CARCINOEMBRYONIC ANTIGENS OF THE HUMAN DIGESTIVE SYSTEM , 1965, The Journal of experimental medicine.
[82] Phil Gold,et al. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES , 1965, The Journal of experimental medicine.
[83] Aung Ko Win,et al. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype , 2013, Modern Pathology.
[84] A. Goel,et al. Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population. , 2011, Bioscience trends.
[85] J. Taylor‐Papadimitriou,et al. ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. , 2011, Frontiers in bioscience.
[86] K. Mizokami,et al. First alert for recurrence during follow-up after potentially curative resection for colorectal carcinoma: CA 19-9 should be included in surveillance programs. , 2010, Clinical colorectal cancer.
[87] Wei Zhang,et al. Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma. , 2008, Oncology reports.
[88] M. Makuuchi,et al. Sialoglycoconjugate expression in primary colorectal cancer and metastatic lymph node tissues. , 2007, Hepato-gastroenterology.
[89] F. dall’Olio,et al. Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948. , 2006, Glycobiology.
[90] T. Irimura,et al. Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of advanced colon carcinoma , 2004, Clinical & Experimental Metastasis.
[91] K. Arisawa,et al. Evaluation of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens expression levels as predictors of recurrence after curative surgery in node-negative colorectal cancer patients. , 2002, Journal of experimental & clinical cancer research : CR.
[92] K. Matsumoto,et al. Genomic structure and transcriptional regulation of human Galbeta1,3GalNAc alpha2,3-sialyltransferase (hST3Gal I) gene. , 2001, Glycobiology.
[93] M. Kitajima,et al. Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. , 1995, Cancer.
[94] T. Irimura,et al. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: liver colonization and adhesion to vascular endothelial cells. , 1995, Experimental cell research.
[95] R. Niemelä,et al. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors. , 1995, International journal of cancer.
[96] D. Hayes,et al. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. , 1989, Cancer communications.
[97] W. Zimmermann,et al. The carcinoembryonic antigen gene family: structure, expression and evolution. , 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[98] N. Kodagoda. Interstitial pneumonitis. , 1972, Ceylon Medical Journal.